RE: Shield Therapeutics PLC Approval for ACCRUFeR in China expected in Q1 202630 Jan 2026 10:15
Shield have renegotiated a lower milestone payment. Never a good start to a partnership.
The market potential is massive but it is like peering through the murky mists trying to figure out what that might be. Can only be positives from here imo but the market needs numbers before take off.
A. Waiting patiently.